The Korea Pharmaceutical Manufacturers Association decided to keep the Exclusive Sales Rights…small and mid-sized pharmaceutical companies blew up with sadness
While the Korea Pharmaceutical Manufacturers Association (KPMA) has made its decision over the Exclusive Sale Rights, it seems that small and mid-sized pharmaceutical companies have shown sadness on the decision.
On the 10th, the KPMA has made its clear decision to keep the Exclusive Sales Right...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
